What Happened?
Shares of life sciences company Avantor (NYSE: AVTR) fell 2.7% in the afternoon session after RBC Capital Markets lowered its price target on the stock to $16 from $17.
Although the investment firm maintained its "Outperform" rating on the provider of mission-critical products and services, the target reduction signals slightly tempered expectations. This move comes amid broader concerns about the company's financial health. An analysis from the previous day highlighted several warning signs, including organic revenue growth that has fallen short of benchmarks over the past two years. Additionally, estimated sales for the next 12 months are projected to be flat, suggesting a softer demand environment, while its free cash flow margin has decreased in recent years.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Avantor? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Avantor’s shares are quite volatile and have had 15 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 12 days ago when the stock gained 5.5% on the news that the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
Avantor is down 38.8% since the beginning of the year, and at $12.98 per share, it is trading 53.2% below its 52-week high of $27.70 from September 2024. Investors who bought $1,000 worth of Avantor’s shares 5 years ago would now be looking at an investment worth $604.09.
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
